Antibody and Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, United Kingdom.
Southampton Experimental Cancer Medicine/Cancer Research U.K. Centre, Protein Core Facility, Cancer Sciences Unit, Southampton General Hospital, Southampton SO16 6YD, United Kingdom.
J Immunol. 2018 Mar 1;200(5):1937-1950. doi: 10.4049/jimmunol.1700832. Epub 2018 Jan 19.
Fc γ receptors (FcγR) are involved in multiple aspects of immune cell regulation, are central to the success of mAb therapeutics, and underpin the pathology of several autoimmune diseases. However, reliable assays capable of accurately measuring FcγR interactions with their physiological ligands, IgG immune complexes (IC), are limited. A method to study and detect IC interactions with FcγRs was therefore developed. This method, designed to model the signaling pathway of the inhibitory FcγRIIB (CD32B), used NanoLuc Binary Interaction Technology to measure recruitment of the Src homology 2 domain-containing inositol phosphatase 1 to the ITIM of this receptor. Such recruitment required prior cross-linking of an ITAM-containing activatory receptor, and evoked luciferase activity in discrete clusters at the cell surface, recapitulating the known biology of CD32B signaling. The assay detected varying forms of experimental IC, including heat-aggregated IgG, rituximab-anti-idiotype complexes, and anti-trinitrophenol-trinitrophenol complexes in a sensitive manner (≤1 μg/ml), and discriminated between complexes of varying size and isotype. Proof-of-concept for the detection of circulating ICs in autoimmune disease was provided, as responses to sera from patients with systemic lupus erythematosus and rheumatoid arthritis were detected in small pilot studies. Finally, the method was translated to a stable cell line system. In conclusion, a rapid and robust method for the detection of IC was developed, which has numerous potential applications including the monitoring of IC in autoimmune diseases and the study of underlying FcγR biology.
Fcγ 受体(FcγR)参与免疫细胞调节的多个方面,是单抗治疗成功的核心,也是几种自身免疫性疾病发病机制的基础。然而,能够准确测量 FcγR 与其生理配体 IgG 免疫复合物(IC)相互作用的可靠检测方法非常有限。因此,开发了一种研究和检测 IC 与 FcγR 相互作用的方法。该方法旨在模拟抑制性 FcγRIIB(CD32B)的信号通路,使用 NanoLuc 二元相互作用技术来测量含有Src 同源 2 结构域的肌醇磷酸酶 1 募集到该受体 ITIM 的情况。这种募集需要预先交联含有 ITAM 的活化受体,并且在细胞表面的离散簇中引发荧光素酶活性,再现了 CD32B 信号的已知生物学特性。该检测方法以敏感的方式(≤1μg/ml)检测到各种形式的实验性 IC,包括热聚集 IgG、利妥昔单抗-抗独特型复合物和抗三硝基苯-三硝基苯复合物,并区分不同大小和同种型的复合物。提供了自身免疫性疾病中循环 IC 检测的概念验证,因为在小型试点研究中检测到来自红斑狼疮和类风湿关节炎患者血清的反应。最后,该方法被转化为稳定的细胞系系统。总之,开发了一种快速而强大的 IC 检测方法,具有许多潜在的应用,包括自身免疫性疾病中 IC 的监测以及对潜在 FcγR 生物学的研究。